Hasil Pencarian - David A Lombardi
- Menampilkan 1 - 16 hasil dari 16
-
1
Advances in occupational traumatic injury research oleh David A Lombardi
Diterbitkan 2017-05-01
Artikel -
2
Chronotypes in the US - Influence of age and sex. oleh Dorothee Fischer, David A Lombardi, Helen Marucci-Wellman, Till Roenneberg
Diterbitkan 2017-01-01
Artikel -
3
-
4
-
5
-
6
Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™) oleh Joseph Reilly, Micah A. Jacobs, Bruce Friedman, Kerry O. Cleveland, David A. Lombardi, Bibiana Castaneda-Ruiz
Diterbitkan 2020-05-01
Artikel -
7
The effects of rest breaks, work shift start time, and sleep on the onset of severe injury among workers in the People’s Republic of China oleh David A Lombardi, Kezhi Jin, Theodore K Courtney, Anna Arlinghaus, Simon Folkard, Youxin Liang, Melissa J Perry
Diterbitkan 2014-03-01
Artikel -
8
-
9
-
10
-
11
Circumstances of fall-related injuries by age and gender among community-dwelling adults in the United States. oleh Lava R Timsina, Joanna L Willetts, Melanye J Brennan, Helen Marucci-Wellman, David A Lombardi, Theodore K Courtney, Santosh K Verma
Diterbitkan 2017-01-01
Artikel -
12
A case-crossover study of work-related acute traumatic hand injuries in the People’s Republic of China oleh Kezhi Jin, David A Lombardi, Theodore K Courtney, Gary S Sorock, Mingqiang Li, Rong Pan, Xiaorong Wang, Jie Lin, Youxin Liang, Melissa J Perry
Diterbitkan 2012-03-01
Artikel -
13
Preventing slips and falls through leisure-time physical activity: findings from a study of limited-service restaurants. oleh Alberto J Caban-Martinez, Theodore K Courtney, Wen-Ruey Chang, David A Lombardi, Yueng-Hsiang Huang, Melanye J Brennan, Melissa J Perry, Jeffrey N Katz, Santosh K Verma
Diterbitkan 2014-01-01
Artikel -
14
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial oleh Dave Singh, Tuan Nguyen, Jacky Woo, Rajeev Saggar, Nathan D Pfeifer, David A Lombardi, Brett Haumann, John Belperio, Maxim Bogus, Valentyn Moskalenko, David L Bourdet, Elad Kaufman, Corbin G Thompson, Edmund J Moran
Diterbitkan 2023-11-01
Artikel -
15
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI oleh Colleen S. Kraft, Matthew Sims, Michael Silverman, Thomas J. Louie, Paul Feuerstadt, Edward S. Huang, Sahil Khanna, Charles S. Berenson, Elaine E. L. Wang, Stuart H. Cohen, Louis Korman, Christine Lee, Colleen R. Kelly, Alberto Odio, Paul P. Cook, Bret Lashner, Mayur Ramesh, Princy Kumar, Ananya De, Asli Memisoglu, David A. Lombardi, Brooke R. Hasson, Barbara H. McGovern, Lisa von Moltke, Darrell S. Pardi, on behalf of the ECOSPOR III and ECOSPOR IV investigators
Diterbitkan 2024-06-01
Artikel -
16
Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI oleh Colleen S. Kraft, Matthew Sims, Michael Silverman, Thomas J. Louie, Paul Feuerstadt, Edward S. Huang, Sahil Khanna, Charles S. Berenson, Elaine E. L. Wang, Stuart H. Cohen, Louis Korman, Christine Lee, Colleen R. Kelly, Alberto Odio, Paul P. Cook, Bret Lashner, Mayur Ramesh, Princy Kumar, Ananya De, Asli Memisoglu, David A. Lombardi, Brooke R. Hasson, Barbara H. McGovern, Lisa von Moltke, Darrell S. Pardi, on behalf of the ECOSPOR III and ECOSPOR IV investigators
Diterbitkan 2024-08-01
Artikel